In vivo anti-tumor efficacy with a dual degrader of SMARCA2 and SMARCA4

  1. Home
  2. In vivo anti-tumor efficacy with a dual degrader of SMARCA2 and SMARCA4
<< Back
April 28, 2023
by admin aurigene

In vivo anti-tumor efficacy with a dual degrader of SMARCA2 and SMARCA4